RA REVANCE AESTHETICS
Live / Registered — Registered (as of 23 Apr 2024)
What this means for you
Registered since 23 Apr 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Apr 2030: the §8 declaration of use).
Record
- Serial number
- 97036604
- Registration number
- 7367695
- Mark type
- Word mark
- Filed
- 20 Sept 2021
- Published for opposition
- 21 Dec 2021
- Registered
- 23 Apr 2024
- Next maintenance filing
- §8 declaration of use, due by 23 Apr 2030 (grace period to 23 Oct 2030)
- Attorney of record
- Jennifer Waitman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of wrinkles; Dermatological pharmaceutical products and pharmaceutical preparations injected into or under the skin, into or under mucous membranes for filling in wrinkles, skin depressions for remodeling, increasing volume in the face, for moisturizing the skin or mucous membranes, for increasing lip volume
Owner
- Revance Therapeutics, Inc., GLENGORMLEY, DE, GB
- Revance Therapeutics, Inc., Nashville, TN
- Revance Therapeutics, Inc., Nashville, TN
Prior registrations
Board proceedings on this mark
The owner also pleads this mark in 2 other Board proceedings.
Prosecution history
- 20 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 20 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Feb 2024 — USE AMENDMENT FILED
- 06 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL